Biologists unravel drug-resistance mechanism in tumor cells
Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.
Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.
Spinout’s microfluidics device better models how cancer and other cells interact in the body.
Researchers discover how the immune system can create cancerous DNA mutations when fighting off infection.
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Researchers discover that aspartate is a limiter of cell proliferation.
Tweaks to the R&D pipeline could create new drugs and greater social benefit.
Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.
MIT collaborates on a smaller, lighter delivery system for proton-beam radiotherapy.
Senior biology and chemistry major Daniel Zhang helps build noninvasive cancer diagnostic tools.
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
Cancer biologist and Koch Institute director recognized with MIT faculty’s top honor.
Bhatia is recognized for her work in tissue engineering, disease detection, and advocacy for women in STEM.
Model from MIT's Computer Science and Artificial Intelligence Laboratory aims to automatically distinguish lymphoma subtypes.